Breaking Stories

Need to Know: Here are Citi’s 10 fresh ways to play disruption — including psychedelic drugs

0

Wall Street is wobbling as we close in on earnings season, which begins in earnest tomorrow. Barring supply-chain woes and labor problems, companies could add to a record-breaking year, but that’s a big “if.”

Our call of the day from a team of more than 20 Citigroup strategists led by Michael Ashford takes us into the hopeful future, with 10 new innovation ideas and accompanying long-term stock ideas to think about.

“A few of the “new” concepts may not seem quite that new — e.g., alternative proteins and psychedelic drugs — but new technology and increased acceptance could make them game-changers,” says the report.

  1. 3-D architecture in semiconductors. Citi says technical complexity in the fabrication— manufacturing of those devices process may, strengthen market leaders’ edge. Its top pick here is Samsung Electronics
    005930,
    -3.50%
    ,
    with LAM Research
    LRCX,
    +0.41%

    and Entegris
    ENTG,
    +1.13%

    also exposed.
  2. AI airline surveillance. Artificial intelligence coming to your next flight could gauge temperature, pulse rates, etc. to detect contagious infections or intoxication. Global network airlines, with high international exposure relative to low-cost peers, should be at the forefront. Citi’s long-term picks include Delta Air Lines
    DAL,
    -0.44%

    and Azul
    AZUL,
    -2.66%
    .

  3. Alternative proteins. Over time, Citi sees more consumers shifting to alternative meats for health or climate change reasons. Beyond Meat
    BYND,
    +1.12%

    and Kellogg
    K,
    +0.11%

    are most exposed to growth of alternative meats, says the bank.
  4. Ammonia propulsion in jet engines. In the race to reduce aviation emissions, ammonia is one solution that’s cheap and feasible. Green ammonia is still some ways away, and Citi sees several zero/low emissions solutions as winners. Its future ammonia plays include Yara
    YAR,
    -1.11%
    ,
    CF Holdings
    CF,
    +1.77%
    ,
    GE
    GE,
    -0.61%

    and International Consolidated Airlines
    IAG,
    -2.68%
    .

  5. De-polymerizing plastics. Advanced chemical recycling systems is seen as a solution to help eliminate plastic waste from landfills, replacing current mechanical recycling systems. Citi sees opportunity for plastic resin producers Dow
    DOW,
    -0.82%
    ,
    LyondellBasell
    LYB,
    -0.55%

    and Arkema
    AKE,
    -0.14%
    .

  6. Direct air capture. Citi expects the process that captures carbon straight from the air to be a key party of energy transition strategies, and require governmental support. Top picks here include Occidental Petroleum
    OXY,
    -0.71%

    and Aker Carbon Capture
    ACC,
    -2.11%
    .

  7. Metaverse malls. In the future of the internet, virtual stores will sell both digital and physical products to consumers who divide their time in both worlds, thanks to smartphones, virtual reality headsets and augmented reality glasses. Facebook
    FB,
    -1.39%

    and Snap
    SNAP,
    -1.96%

    are two ways to play this, says Citi.
  8. mRNA vaccines. A year ago, the leading technology for COVID-19 vaccines was viewed as largely unproven, and now trials are under way to treat several infectious diseases, with genetic diseases and even cancer among future possibilities. Sanofi
    SNY,
    -0.67%

    SAN,
    -0.55%
    ,
    Arcturus
    ARCT,
    +1.56%

    and Pfizer
    PFE,
    -0.92%

    are among Citi’s top picks.

  9. Nonfungible tokens – NFTs. Beneficiaries include companies or individuals whose main business is selling content or branded goods, one that enables the creation, minting, staking, sharing or trading of NFTs in the secondary market, and service companies that help content creators navigate this new ecosystem. Beneficiaries include Robinhood
    HOOD,
    +0.69%
    ,
    Discovery
    DISCA,
    -2.78%
    ,
    Disney
    DIS,
    -1.82%
    ,
    WPP
    WPP,
    +0.21%

    WPP,
    -0.20%

    and Publicis
    PUB,
    -0.84%
    .

  10. Psychedelic drugs is Citi’s last disruptive idea. “Despite their checkered history, psychedelic drugs such as LSD, psilocybin (“magic mushrooms”), and DMT (ayahuasca) are making a comeback, and could revolutionize the mental-health treatment paradigm. Top picks include ATAI Life Sciences
    ATAI,
    +0.24%

    and COMPASS Pathways
    CMPS,
    -1.21%
    .

Here’s a visual on all that:

The buzz

On the earnings front, industrial distributor Fastenal
FAST,
-0.93%

will report, with JPMorgan
JPM,
-2.10%

hitting Wednesday and more big names throughout the rest of the week.

Tesla
TSLA,
+0.82%

reportedly sold a record number of its electric cars in China last month.

A short selling research firm says it has covered its bet against movie-theater chain AMC Entertainment
AMC,
+0.16%

at a profit, but it may not be done placing bets.

Dogged by labor shortage worries, a closely watched small-business confidence gauge hit a six-month low in September. We’ll also get job openings and the International Monetary Fund’s world economic outlook. Consumer prices are coming Wednesday and retail sales Friday.

Read: The 2021 stock-market highs are ‘almost certainly’ in, unless earnings clear this bar

Beijing is probing whether financial firms and regulators have been getting too cozy with private companies such as Alibaba’s
BABA,
+1.50%

Ant Group and ride-hailing group Didi
DIDI,
+2.57%
.

And another China property company, Sinic Holdings, may be veering into default.

Meanwhile, China’s coal futures hit another record amid massive, deadly floods in the country’s important northern mining region.

Listen to MarketWatch’s new podcast — The Best New Ideas in Money.

The markets

Stock futures
ES00,
+0.09%

YM00,
+0.03%

NQ00,
+0.27%

are on the fence, following losses across Asia
000300,
-1.06%

HSI,
-1.43%
.
U.S. crude remains above $80 a barrel. Bitcoin is trading just over $57,000, brushing off JPMorgan CEO Jamie Dimon’s “bitcoin is worthless” comments.

The chart

Buying the “Evergrande dip is the first one this year that has immediately paid off,” for investors, notes Mike Wilson, Morgan Stanley’s equity strategist, who provides the above chart in a note to clients. And it’s a key question to ask going forward — will the retail community keep buying that dip, he says.

“We think it depends on how fast the market can reclaim prior support. The sooner the better because earnings season is unlikely to provide the necessary catalyst,” he says.

Random reads

A Colorado elk with a tire around his neck is finally free of it after four years.

How is life for Americans under President Joe Biden? Thousands respond to this Redditor’s question.

Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.

Want more for the day ahead? Sign up for The Barron’s Daily, a morning briefing for investors, including exclusive commentary from Barron’s and MarketWatch writers.

Market Snapshot: Wall Street flails for direction ahead of earnings

Previous article

Futures Movers: Oil extends rise as U.S. benchmark adds to push above $80 a barrel

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *